scholarly journals Automatic Extraction of Lung Cancer Staging Information from Chinese Computed Tomography Reports: Deep Learning Approach (Preprint)

2021 ◽  
Author(s):  
Danqing Hu ◽  
Shaolei Li ◽  
Yuhong Wang ◽  
Huanyao Zhang ◽  
Nan Wu ◽  
...  

BACKGROUND Lung cancer is the leading cause of cancer death worldwide. Clinical staging of lung cancer plays a crucial role in treatment decision making and prognosis evaluation. However, in clinical practice, about one-half of the clinical stages of lung cancer patients are inconsistent with their pathological stages. As one of the most important diagnostic modalities for staging, chest computed tomography reports a wealth of information about cancer staging, but the free-text nature of the reports obstructs their computerized utilization. OBJECTIVE In this paper, we aim to automatically extract the staging-related information from CT reports to support accurate clinical staging. METHODS In this study, we developed an information extraction system to extract the staging-related information from CT reports. The system consisted of three parts, i.e., named entity recognition (NER), relation classification (RC), and question reasoning (QR). We first summarized 22 questions about lung cancer staging based on the TNM staging guideline. And then, two state-of-the-art NER algorithms were implemented to recognize the entities of interest. Next, we presented a novel RC method using the relation constraints to classify the relations between entities. Finally, a rule-based QR module was established to answer all questions by reasoning the results of NER and RC. RESULTS We evaluated the developed IE system on a clinical dataset containing 392 chest CT reports collected from the Department of Thoracic Surgery II of Peking University Cancer Hospital. The experimental results show that the Bi-LSTM-CRF outperforms the ID-CNN-CRF for the NER task with 77.27% and 89.96% macro F1 scores under the exact and inexact matching scheme, respectively. For the RC task, the proposed method, i.e., Attention-Bi-LSTM with relation constraints, achieves the best performances with 96.53% micro F1 score and 98.27% macro F1 score in comparison with CNN-MF and Attention-Bi-LSTM. Moreover, the rule-based QR module can correctly answer the staging questions by reasoning the extracted results of NER and RC, which achieves 93.56% macro F1 score and 94.73% micro F1 score for all 22 questions. CONCLUSIONS We conclude that the developed IE system can effectively and accurately extract the information about lung cancer staging from the CT reports. Experimental results show that the extracted results have great potential for further utilization in stage verification and prediction to facilitate accurate clinical staging.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. 2044-2044
Author(s):  
Felipe Torres ◽  
Shazia Akbar ◽  
Felix Baldauf-Lenschen ◽  
Natasha B. Leighl

2044 Background: Clinical TNM staging derived from computed tomography (CT) imaging is a key prognostic factor for lung cancer patients when making decisions about treatment, monitoring, and clinical trial eligibility. However, heterogeneity among patients, including by molecular subtypes, may result in variability of survival outcomes of patients with the same TNM stage that receive the same treatment. Artificial intelligence may offer additional, individualized prognostic information based on both known and unknown features present in CTs to facilitate more precise clinical decision making. We developed a novel deep learning-based technique to predict 2-year survival from pretreatment CTs of pathologically-confirmed lung cancer patients. Methods: A fully automated, end-to-end model was designed to localize the three-dimensional (3D) space comprising the lungs and heart, and to learn deep prognostic features using a 3D convolutional neural network (3DCNN). The 3DCNN was trained and validated using 1,841 CTs of 1,184 patients from five public datasets made available in The Cancer Imaging Archive. Spearman’s rank correlation (R) and concordance index (C-index) between the model output and survival status of each patient after 2-year follow-up from CT acquisition was assessed, in addition to sensitivity, specificity and accuracy stratified by staging. Results: 3DCNN showed an overall prediction accuracy of 75.0% (R = 0.32, C-index = 0.67, p < 0.0001), with higher performance achieved for stage I patients (Table) . 3DCNN showed better overall correlation with survival for 1,124 patients with available TNM staging, in comparison to TNM staging only (R = 0.19, C-index = 0.63, p < 0.0001); however, a weighted linear combination of both TNM staging and the 3DCNN yielded a superior correlation (R = 0.34, C-index = 0.73, p < 0.0001). Conclusions: Deep learning applied to pretreatment CT images provides personalized prognostic information that complements clinical staging and may help facilitate more precise prognostication of patients diagnosed with lung cancer. [Table: see text]


Chest Imaging ◽  
2019 ◽  
pp. 281-287
Author(s):  
Ryo E. C. Benson

Lung cancer staging is a process used to assess the extent of spread of lung cancer, determine the most appropriate treatment and predict the patient’s prognosis. Clinical staging is performed prior to surgical resection, while surgical-pathologic staging is based on histologic analysis of the resected tumor and lymph nodes. Restaging is performed following treatment. Staging is based on the TNM classification system. T refers to the primary tumor, N to thoracic lymph node involvement and M to metastatic disease. Recent changes to T and M descriptors were made to better reflect actual survival. For the majority of non-small cell lung cancers, the presence or absence of mediastinal lymph node spread is the most important outcome predictor. Although no changes were made to the N descriptor, the actual intrathoracic lymph node stations were recently clarified. Although the majority of small cell lung cancers are metastatic at the time of presentation, the presence of limited versus extensive spread of disease determines treatment options. However, the overall prognosis and survival for affected patients is poor. TNM staging is now recommended for carcinoid tumors as well as small cell lung cancer.


1982 ◽  
Vol 84 (4) ◽  
pp. 569-574 ◽  
Author(s):  
Claudio Modini ◽  
Roberto Passariello ◽  
Clemente Iascone ◽  
Franco Cicconetti ◽  
Giovanni Simonetti ◽  
...  

2007 ◽  
Vol 131 (7) ◽  
pp. 1016-1026
Author(s):  
Douglas B. Flieder

Abstract Context.—Lung cancer is the leading cause of cancer mortality worldwide. Despite technological, therapeutic, and scientific advances, most patients present with incurable disease and a poor chance of long-term survival. For those with potentially curable disease, lung cancer staging greatly influences therapeutic decisions. Therefore, surgical pathologists determine many facets of lung cancer patient care. Objective.—To present the current lung cancer staging system and examine the importance of mediastinal lymph node sampling, and also to discuss particularly confusing and/or challenging areas in lung cancer staging, including assessment of visceral pleura invasion, bronchial and carinal involvement, and the staging of synchronous carcinomas. Data Sources.—Published current and prior staging manuals from the American Joint Committee on Cancer and the International Union Against Cancer as well as selected articles pertaining to lung cancer staging and diagnosis accessible through PubMed (National Library of Medicine) form the basis of this review. Conclusions.—Proper lung cancer staging requires more than a superficial appreciation of the staging system. Clinically relevant specimen gross examination and histologic review depend on a thorough understanding of the staging guidelines. Common sense is also required when one is confronted with a tumor specimen that defies easy assignment to the TNM staging system.


2016 ◽  
Vol 141 (7) ◽  
pp. 923-926 ◽  
Author(s):  
Sanja Dacic

Context.— The International Association for the Study of Lung Cancer Staging Committee has prospectively created an international lung cancer database that was used to address many lung cancer staging questions, such as tumor size, nodal status, and metastatic disease. The proposed changes for the upcoming 8th edition of the cancer staging manual were based on survival data and better prognostic stratification of patients with lung cancer. Objectives.— To review published recommendations for the revision of lung carcinoma TNM staging and to address potential challenges in pathologic staging. Data Source.— PubMed available articles by the International Association for the Study of Lung Cancer Staging Committee were reviewed. Conclusions.— The TNM system remains the best prognosticator of lung cancer outcome. The recommendations are established on new prospective data analysis and reflect the improvements in prognostic separation of patients with lung cancer based on a multidisciplinary approach.


Sign in / Sign up

Export Citation Format

Share Document